biotech · Recurrent Plasma Cell Myeloma · Anal Cancer Metastatic · ONCY
Oncolytics Biotech
ONCOLYTICS BIOTECH INC
Oncolytics Biotech clinical programs — 23 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 4350 Executive Dr, 325, San Diego, California 92121, US
- Founded
- 1998
- Employees
- 46
- Programs
- 23
- Drugs
- 14
- Patents
- 66
Oncolytics Biotech projects
23 ClinicalTrials.gov programs sponsored by Oncolytics Biotech.
Oncolytics Biotech has 23 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
REOLYSIN
ONCOLYTICS BIOTECH INC
Carcinoma, Squamous Cell of the Head and Neck
2 trials -
Bevacizumab
ONCOLYTICS BIOTECH INC
Ras-mutated Metastatic Colorectal Cancer
1 trial -
Docetaxel, Reolysin and Prednisone
ONCOLYTICS BIOTECH INC
Prostate Cancer
1 trial -
Folfox plus Bevacizumab and reolysin
ONCOLYTICS BIOTECH INC
Colorectal Cancer
1 trial -
Paclitaxel
ONCOLYTICS BIOTECH INC
Metastatic Breast Cancer
1 trial -
Paclitaxel
ONCOLYTICS BIOTECH INC
Breast Cancer Metastatic
1 trial -
Pelareorep
ONCOLYTICS BIOTECH INC
Anal Cancer Metastatic
1 trial -
Pelareorep
ONCOLYTICS BIOTECH INC
Anatomic Stage IV Breast Cancer AJCC v8
1 trial -
Pemetrexed and Reolysin (and safety run-in)
ONCOLYTICS BIOTECH INC
Non Small Cell Lung Cancer
1 trial -
REO 029
ONCOLYTICS BIOTECH INC
Patients with advanced or metastatic gastrointestinal (GI) tumors.
1 trial -
REOLYSIN
ONCOLYTICS BIOTECH INC
Metastatic Pancreatic Adenocarcinoma
1 trial -
REOLYSIN
ONCOLYTICS BIOTECH INC
Metastatic Melanoma
1 trial -
REOLYSIN
ONCOLYTICS BIOTECH INC
Metastatic or Recurrent Squamous Cell Carcinoma of the Lung
1 trial -
REOLYSIN®
ONCOLYTICS BIOTECH INC
Carcinoma, Non-small Cell Lung
1 trial -
REOLYSIN®
ONCOLYTICS BIOTECH INC
Osteosarcoma
1 trial -
Bortezomib
ONCOLYTICS BIOTECH INC
Recurrent Plasma Cell Myeloma
1 trial -
Carfilzomib
ONCOLYTICS BIOTECH INC
Recurrent Plasma Cell Myeloma
1 trial -
Lenalidomide or Pomalidomide
ONCOLYTICS BIOTECH INC
Multiple Myeloma
1 trial -
Pelareorep
ONCOLYTICS BIOTECH INC
Breast Cancer
1 trial -
REOLYSIN®
ONCOLYTICS BIOTECH INC
Pancreatic Adenocarcinoma
1 trial -
REOLYSIN®
ONCOLYTICS BIOTECH INC
KRAS Mutant Metastatic Colorectal Cancer
1 trial -
REOLYSIN®
ONCOLYTICS BIOTECH INC
Malignant Glioma
1 trial -
REOLYSIN®
ONCOLYTICS BIOTECH INC
Muscle-invasive Transitional Cell Carcinoma of the Bladder
1 trial
Frequently asked questions
How many clinical projects does Oncolytics Biotech have?
23 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.